Search by Drug Name or NDC

    NDC 68180-0721-03 Amlodipine Besylate 10 mg/1 Details

    Amlodipine Besylate 10 mg/1

    Amlodipine Besylate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is AMLODIPINE BESYLATE.

    Product Information

    NDC 68180-0721
    Product ID 68180-721_9b50425d-772f-4bb2-a1f6-c4b289b54850
    Associated GPIs 34000003100340
    GCN Sequence Number 016927
    GCN Sequence Number Description amlodipine besylate TABLET 10 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02682
    HICL Sequence Number 006494
    HICL Sequence Number Description AMLODIPINE BESYLATE
    Brand/Generic Generic
    Proprietary Name Amlodipine Besylate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amlodipine Besylate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name AMLODIPINE BESYLATE
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078043
    Listing Certified Through 2025-12-31

    Package

    NDC 68180-0721-03 (68180072103)

    NDC Package Code 68180-721-03
    Billing NDC 68180072103
    Package 1000 TABLET in 1 BOTTLE (68180-721-03)
    Marketing Start Date 2018-10-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.0172
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description AMLODIPINE BESYLATE 10 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis